Cargando…
Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival
BACKGROUND: Cancer cachexia is a catabolic condition characterized by skeletal muscle wasting, consequent to tumor burden, which negatively impacts tolerance to cancer therapies and contributes to increased mortality. Partly because of the limited knowledge of the underlying mechanisms of cancer cac...
Autores principales: | Judge, Sarah M, Nosacka, Rachel L, Delitto, Daniel, Gerber, Michael H, Cameron, Miles E, Trevino, Jose G, Judge, Andrew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322478/ https://www.ncbi.nlm.nih.gov/pubmed/30637373 http://dx.doi.org/10.1093/jncics/pky043 |
Ejemplares similares
-
Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
por: Nosacka, Rachel L., et al.
Publicado: (2020) -
IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy
por: Callaway, Chandler S., et al.
Publicado: (2019) -
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
por: Neyroud, Daria, et al.
Publicado: (2021) -
Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia
por: Delitto, Daniel, et al.
Publicado: (2016) -
Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
por: Gerber, Michael H., et al.
Publicado: (2018)